The rapidly evolving Coronavirus (COVID-19) situation has significantly impacted the research and innovation community. As a new virus with no specific vaccines or treatments; advancing knowledge about the virus and researching new ways to understand and treat is critical.
The Chief Scientist Office (CSO) of Scottish Government, NHS Research Scotland (NRS) and Health Board R&D Offices are working closely, and in collaboration with equivalents across the UK nations to identify studies which should be given highest priority. This recognises the extraordinary pressures currently faced by the health and care system and is designed to prevent duplication of effort and ensure that the resources and capacity of the health system are not exceeded.
Media enquiries specific to research can be directed to Fiona Fleming, Communications Manager:
General Coronavirus (COVID-19) enquiries should be directed to Scottish Government on 0131 244 0222.
NHS 24 is the primary source of public health information in Scotland - www.nhsinform.scot/coronavirus.
Arrangements for clinical trials/studies in NHS Boards
Prioritisation of COVID-19 research
Guidance for researchers, sponsors and sites
CSO Statement on research Restart Framework
Recruiting patients for clinical trials
Other Key Areas
- Information for the public on COVID-19 research
- Prioritising funding and support for COVID-19 research across the UK
- Scottish Government COVID-19 Advisory Group
- COVID-19: safe handling and processing for samples in laboratories
- Chief Scientist Office (CSO)
- Health Research Authority (HRA)
- National Institute for Health Research (NIHR)
- Research projects for educational purposes
- Research ethics resilience